Foshan Wandesheng Sanitary Ware Co., Ltd. – Trademark Portfolio

Entity Type: 16

Foshan Wandesheng Sanitary Ware Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BONADAYS. The owner is based in Foshan City.

No. 13-6, West Qunjian Development Zone, Ditian Village Committee, Nanzhuang Town, Chancheng District,

Foshan City 528000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BONADAYS
BONADAYS
Registered 2025

Trademark Classifications

Foshan Wandesheng Sanitary Ware Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does Foshan Wandesheng Sanitary Ware Co., Ltd. have?

Foshan Wandesheng Sanitary Ware Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Foshan Wandesheng Sanitary Ware Co., Ltd. file in?

Foshan Wandesheng Sanitary Ware Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 20 (Furniture). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Foshan Wandesheng Sanitary Ware Co., Ltd.'s most well-known trademarks?

Foshan Wandesheng Sanitary Ware Co., Ltd.'s registered trademark portfolio includes well-known marks such as BONADAYS. These are among 1 currently registered trademark in the portfolio.

What is Foshan Wandesheng Sanitary Ware Co., Ltd.'s trademark registration success rate?

Foshan Wandesheng Sanitary Ware Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.